Skin & Wound Healing Research Stack

Reviewed by the BestHealingPeptides Editorial Team · 2026-06-20

Address dermal collagen synthesis, angiogenesis, and antimicrobial defence in pre-clinical wound-healing models.

Components

Protocol notes

Topical formulation chemistry matters more than peptide identity alone — vehicle viscosity, pH, and copper-redox interactions all influence outcomes. Run each peptide individually and as a combination, with a vehicle-only control on every animal.

Mechanistic rationale

GHK-Cu drives dermal collagen, elastin, and antioxidant gene expression in fibroblasts through copper delivery to lysyl oxidase (collagen and elastin cross-linking) and superoxide dismutase (intracellular antioxidant defence), plus broad transcriptional modulation documented across >4,000 genes in Pickart's microarray characterisation. It additionally suppresses TGF-β1-driven Smad-2/3 phosphorylation, restraining myofibroblast differentiation and pathological hypertrophic scarring. BPC-157 contributes angiogenic and anti-inflammatory effects via VEGFR2-eNOS-driven capillary regeneration and NO-system stabilisation — particularly relevant in vascular wound beds and the zone-of-stasis peripheral to burn injuries. LL-37 contributes direct broad-spectrum antimicrobial activity against wound pathogens (Pseudomonas, MRSA) plus host re-epithelialisation signalling through EGFR transactivation on keratinocytes and FPR2-mediated angiogenesis on endothelium — the dual antimicrobial-and-repair profile is useful in contaminated or chronic wound models where infection burden limits healing.

Endpoint suggestions

Wound-closure rate measured by digital planimetry over sequential days is the primary functional readout. Re-epithelialisation is assessed histologically by measuring epithelial gap width on H&E sections. Microvessel density by CD31 immunohistochemistry captures the angiogenic response. Hydroxyproline content in tissue homogenates provides a quantitative biochemical collagen readout. Tensile strength of healed tissue on a materials-testing frame captures functional recovery. Additional endpoints: collagen type-I/-III ratio and organisation (picrosirius red with polarised light), Ki-67 for keratinocyte proliferation, alpha-SMA for myofibroblast density (relevant for hypertrophic scar risk), and TGF-β1 tissue expression by ELISA. In infected-wound models, bacterial colony counts (CFU/g tissue) add antimicrobial-endpoint characterisation.

Confounders

Formulation vehicle chemistry dominates topical study outcomes. Combining GHK-Cu with reducing agents (vitamin C, sulfites) in a single vehicle disrupts the Cu²⁺ complex — separate application or careful vehicle selection is required. GHK-Cu at high concentrations combined with EDTA chelates the copper away from lysyl oxidase target sites. LL-37 binds plasma proteins avidly (alpha-2-macroglobulin, LDL, heparan sulphate proteoglycans reduce free effective concentration), and its cationic nature drives substantial adsorption to standard polystyrene and polypropylene labware — use low-binding vessels and consider BSA supplementation (0.01-0.1%) for accurate concentrations. UV exposure between dosing sessions confounds wound-healing outcomes and should be standardised. Diabetic-model choice (streptozotocin, db/db, high-fat-diet-obese-induced insulin resistance) materially affects healing trajectory.

Where to source research peptides for laboratory research

The following UK-based suppliers stock research-grade, lyophilised peptides for in-vitro and pre-clinical work. Purity and provenance vary; always request a Certificate of Analysis (CoA) and confirm cold-chain storage on arrival. None of the products linked below are approved for human use.

PeptideAuthority.co.uk
UK-based research peptide supplier with batch certificates of analysis and >99% purity testing.
PeptideBarn.co.uk
Wide catalogue of research-grade lyophilised peptides shipped from the UK, including bulk vials.